Literature DB >> 24648933

Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients.

Fanping Meng1, Xiaojuan Yin2, Xuemei Ma1, Xiao-Dong Guo3, Bo Jin1, Hanwei Li1.   

Abstract

A variety of laboratory tests are used in the evaluation of hepatic patients. Serum cholinesterase is reduced in liver dysfunction in contrast to other enzymes. The aim of this study was to assess the value of serum cholinesterase in evaluating liver reserve function in cirrhotic patients. A total of 866 cirrhotic patients were divided into three groups according to their Child-Pugh score. Serum cholinesterase of the patients was detected using the enzyme rate method. Simultaneously, serum albumin was detected using the bromocresol green test, while serum plasma prothrombin time was detected using the clotting assay. Using analysis of variance, the value of serum cholinesterase was analyzed in evaluating the liver reserve function of cirrhotic patients in different Child grades. Using correlation analysis, the correction between cholinesterase and albumin and serum plasma prothrombin time was analyzed. Cirrhotic patients were grouped strictly into A, B and C grades, as per the Child-Pugh score. The results showed that cholinesterase tended to significantly decrease in the three grades Child A (5368.04±1657.32 U/l), Child B (2943.06±1212.84 U/l) and Child C (1832.51±710.68 U/l) (F=264.135, P=0.000). In patients with cirrhosis, cholinesterase was positively correlated with albumin and negatively correlated with serum plasma prothrombin time. In the Child A grade, serum cholinesterase was positively correlated with albumin, but negatively correlated with serum plasma prothrombin time. In the Child B grade, serum cholinesterase remained negatively correlated with serum plasma prothrombin time although there was no significant correlation between cholinesterase and albumin. In the Child C grade, serum cholinesterase positively correlated with albumin, but there was no significant correlation between cholinesterase and serum plasma prothrombin time. In conclusion, correlated with the damage severity of liver cells, cholinesterase may respond to liver reserve function.

Entities:  

Keywords:  Child-Pugh score; albumin; liver cirrhosis; prothrombin time; serum cholinesterase

Year:  2013        PMID: 24648933      PMCID: PMC3917072          DOI: 10.3892/br.2013.60

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  9 in total

1.  [Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver].

Authors:  Z Zou; S Xin; B Li
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2001-12

2.  [Establishing indicators for diagnosis of cholinergic crisis].

Authors:  Kazuko Kariyone; Yoshimi Shimatani; Toshikazu Kurihara; Takehiko Nagao; Yoshika Fujita; Masayoshi Uesugi
Journal:  Rinsho Byori       Date:  2010-10

3.  Acetyl cholinesterase is expressed in the follicular dendritic cells of germinal centres: differences between normal and neoplastic follicles.

Authors:  I A Lampert; S Van Noorden
Journal:  J Pathol       Date:  1996-10       Impact factor: 7.996

4.  Studies on the distribution of cholinesterases: activity in the human and dog heart.

Authors:  S N Sinha; S Keresztes-Nagy; A Frankfater
Journal:  Pediatr Res       Date:  1976-08       Impact factor: 3.756

5.  Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis.

Authors:  M Kondo; T Hada; K Fukui; A Iwasaki; K Higashino; K Yasukawa
Journal:  Clin Chim Acta       Date:  1995-12-15       Impact factor: 3.786

Review 6.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

7.  Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure.

Authors:  Hitendra Garg; Ashish Kumar; Vishal Garg; Praveen Sharma; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Dig Liver Dis       Date:  2011-10-05       Impact factor: 4.088

8.  Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests.

Authors:  O O Ogunkeye; A I Roluga
Journal:  Pathophysiology       Date:  2006-03-10

9.  Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method.

Authors:  Vratislav Chromý; Lenka Sváchová; Lukás Novosád; Jirí Jarkovský; Pavel Sedlák; Petr Horák; Hana Dobrovolná; Barbora Hlavácová
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

  9 in total
  15 in total

1.  Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.

Authors:  Mingyue Cai; Wensou Huang; Chaoshuang Lin; Zhengran Li; Jiesheng Qian; Mingsheng Huang; Zhaolin Zeng; Jingjun Huang; Hong Shan; Kangshun Zhu
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

2.  New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.

Authors:  Shintaro Yagi; Toshimi Kaido; Taku Iida; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Today       Date:  2016-11-11       Impact factor: 2.549

3.  Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.

Authors:  Muhammad Fawad Rasool; Feras Khalil; Stephanie Läer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

4.  Prediction of liver injury using the BP-ANN model with metabolic parameters in overweight and obese Chinese subjects.

Authors:  Lufeng Hu; Fan Wang; Jinzhong Xu; Xiaofang Wang; Hong Lin; Yi Zhang; Yang Yu; Youpei Wang; Lingxia Pang; Xi Zhang; Qi Liu; Guoshi Qiu; Yongsheng Jiang; Longteng Xie; Yanlong Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients.

Authors:  Aleksandar R Zivkovic; Karsten Schmidt; Annette Sigl; Sebastian O Decker; Thorsten Brenner; Stefan Hofer
Journal:  Mediators Inflamm       Date:  2015-02-11       Impact factor: 4.711

6.  Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D.

Authors:  Minaam Abbas; Zaigham Abbas
Journal:  World J Hepatol       Date:  2017-08-08

7.  A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis.

Authors:  Aleksandar R Zivkovic; Sebastian O Decker; Anne C Zirnstein; Annette Sigl; Karsten Schmidt; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  Mediators Inflamm       Date:  2018-04-29       Impact factor: 4.711

8.  Successful management of zinc phosphide poisoning-a Hungarian case.

Authors:  Gergely Bilics; Júlia Héger; Éva Pozsgai; Gábor Bajzik; Csaba Nagy; Csilla Somoskövi; Csaba Varga
Journal:  Int J Emerg Med       Date:  2020-09-18

9.  Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.

Authors:  Bang-Ning Cheng; Yu-Lian Jin; Bi-Quan Chen; Li-Yan Zhu; Zi-Cheng Xu; Tao Shen
Journal:  Infect Dis Poverty       Date:  2016-03-29       Impact factor: 4.520

10.  Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages.

Authors:  Takumi Hirata; Yasumichi Arai; Shinsuke Yuasa; Yukiko Abe; Michiyo Takayama; Takashi Sasaki; Akira Kunitomi; Hiroki Inagaki; Motoyoshi Endo; Jun Morinaga; Kimio Yoshimura; Tetsuo Adachi; Yuichi Oike; Toru Takebayashi; Hideyuki Okano; Nobuyoshi Hirose
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.